Acute Myeloid Leukemia Pipeline Insight | Key Companies - Takeda, Bristol-Myers Squibb, Allogene Therapeutics, Novartis, Janssen, Teva Pharma, Bristol-Myers Squibb, and Others

MLA

“Acute Myeloid Leukemia Pipeline Insight | Key Companies - Takeda, Bristol-Myers Squibb, Allogene Therapeutics, Novartis, Janssen, Teva Pharma, Bristol-Myers Squibb, and Others.” M2 Presswire, 24 May 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.750370980&authtype=sso&custid=ns315887.

APA

Acute Myeloid Leukemia Pipeline Insight | Key Companies - Takeda, Bristol-Myers Squibb, Allogene Therapeutics, Novartis, Janssen, Teva Pharma, Bristol-Myers Squibb, and Others. (2023, May 24). M2 Presswire.

Chicago

M2 Presswire. 2023. “Acute Myeloid Leukemia Pipeline Insight | Key Companies - Takeda, Bristol-Myers Squibb, Allogene Therapeutics, Novartis, Janssen, Teva Pharma, Bristol-Myers Squibb, and Others,” May 24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.750370980&authtype=sso&custid=ns315887.